Gene · 6646
Papers1,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of gene signatures and molecular mechanisms underlying the mutual exclusion between psoriasis and leprosy. | Sci Rep | 2024 | 38273053 | PubTator, text mining | PubMed |
| Emerging Lipid Targets in Glioblastoma. | Cancers (Basel) | 2024 | 38254886 | PubTator, text mining | PubMed |
| The mediation effect of HDL-C: Non-HDL-C on the association between inflammatory score and recurrent coronary events. | Heliyon | 2024 | 38187341 | PubTator, text mining | PubMed |
| Relevance of the endoplasmic reticulum-mitochondria axis in cancer diagnosis and therapy. | Exp Mol Med | 2024 | 38172597 | PubTator, text mining | PubMed |
| Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38172098 | PubTator, text mining | PubMed |
| Acyl-coenzyme A: cholesterol acyltransferase inhibitor avasimibe suppresses tumorigenesis and induces G1-phase cell-cycle arrest by activating PPARγ signaling pathway in bladder cancer. | J Cancer | 2024 | 38169575 | PubTator, text mining | PubMed |
| Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health. | Arch Toxicol | 2024 | 38147116 | PubTator, text mining | PubMed |
| Identification of Proteome-Based Immune Subtypes of Early Hepatocellular Carcinoma and Analysis of Potential Metabolic Drivers. | Mol Cell Proteomics | 2024 | 38008179 | PubTator, text mining | PubMed |
| EMC rectifies the topology of multipass membrane proteins. | Nat Struct Mol Biol | 2024 | 37957425 | PubTator, text mining | PubMed |
| Forecasting the dynamics of a complex microbial community using integrated meta-omics. | Nat Ecol Evol | 2024 | 37957315 | PubTator, text mining | PubMed |
| The role of KLF2 in regulating hepatic lipogenesis and blood cholesterol homeostasis via the SCAP/SREBP pathway. | J Lipid Res | 2024 | 37949368 | PubTator, text mining | PubMed |
| LncRNAs-circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers. | Adv Sci (Weinh) | 2024 | 37939296 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells as a Possible Approach for Exploring the Pathophysiology of Polycystic Ovary Syndrome (PCOS). | Stem Cell Rev Rep | 2024 | 37768523 | PubTator, text mining | PubMed |
| The lipid basis of cell death and autophagy. | Autophagy | 2024 | 37768124 | PubTator, text mining | PubMed |
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. | Int Wound J | 2024 | 37697692 | PubTator, text mining | PubMed |
| Discovery of autophagy as a universal mechanism for sex steroid synthesis in human ovary and testis. | Autophagy Rep | 2023 | 40395319 | PubTator, text mining | PubMed |
| Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins. | Int J Mol Sci | 2023 | 38203494 | PubTator, text mining | PubMed |
| Sevoflurane attenuates proliferative and migratory activity of lung cancer cells via mediating the microRNA-100-3p/sterol O-Acyltransferase 1 axis. | Chin J Physiol | 2023 | 38149558 | PubTator, text mining | PubMed |
| Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia. | Antioxidants (Basel) | 2023 | 38136203 | PubTator, text mining | PubMed |
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6646/papers?page=7